Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

November 2, 2022
BioUtah News
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

November 2, 2022
BioUtah News
Myriad Genetics Reports Third Quarter Financial Results

Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance.

November 1, 2022
BioUtah News
Renalytix Reports Full Year Fiscal 2022 Results

Renalytix announced its full year results for the twelve months ended 30 June 2022.

November 1, 2022
BioUtah News
Merit Medical Reports Results for Quarter Ended September 30, 2022

Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.

October 27, 2022
BioUtah News
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

October 25, 2022
BioUtah News
KidneyIntelX Medicare Update

Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage.

October 19, 2022
BioUtah News
15th Annual 2022 Women Tech Award Recipients

The Women’s Tech Council announced eight award recipients from its twenty one finalists.

October 19, 2022
BioUtah News
Geneial Receives $2.3M NIH Grant

Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.

October 19, 2022
BioUtah News
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS

SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy (DOE) to develop, design and characterize 3D-printed alumina ceramic heat exchangers for heating, ventilation, and air conditioning systems (HVAC).

October 19, 2022
BioUtah News
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE

SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop and test an antimicrobial trauma device.

October 19, 2022
BioUtah News
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs

CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations

October 19, 2022
BioUtah News
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer

Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday.

October 19, 2022
BioUtah News
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology

Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost economics for Medicare population.

October 13, 2022
Policy News
Senator Mike Lee Introduces Bill to Roll Back Government Drug Price Controls

Senator Mike Lee (R-UT) has introduced the “Protecting Drug Innovation Act” which would roll back Medicare’s authority to set drug prices through a new punitive negotiation program. This government price-setting policy was a key component of the Democrats’ “Inflation Reduction Act” (IRA). The non-partisan Congressional Budget Office has estimated that the IRA’s drug pricing provisions […]

October 13, 2022
Policy News
Senator Mike Lee Urges Action for Transitional Coverage of Innovative Med Tech

Senator Mike Lee (R-UT) and a group of like-minded colleagues are preparing to send a letter to CMS Administration Chiquita Brooks-LaSure urging the agency to issue a proposed rule by year’s end to provide accelerated Medicare coverage for emerging medical technologies. Medicare patients should have timely access to innovative and beneficial care, which can change […]

October 13, 2022
BioUtah News
EVŌQ Bio is Fielding Partnership Inquiries for its Antimicrobial Medical Materials Additives at the MedTech Conference

 Attendance at premiere medical technology convention to spur partnership, growth opportunities. SALT LAKE CITY, October 10, 2022 /PRNewswire/ – EVŌQ Bio (an EVŌQ Nano company), a nano-platform technology company, is pleased to announce their attendance at the MedTech Conference 2022 in Boston, Massachusetts October 24-26, 2022. The MedTech Conference is the premiere venue for executives […]

October 13, 2022
BioUtah News
Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”) for a new prescription monitoring device for infants. The Company’s device, which uses pulse oximetry technology, is intended to be prescribed by physicians for assisting with the in-home monitoring […]

October 13, 2022
BioUtah News
Phoenix PharmaLabs Awarded $8.7 Million Grant from NIDA to Study Compound for Treatment of Cocaine Use Disorder

Woods Cross, UT (October 6, 2022) – Phoenix PharmaLabs, Inc. (https://phoenixpharmalabs.com), a private company developing potent, non-addictive treatments for pain and addiction, today announced the receipt of an $8.7 million grant from the National Institute on Drug Abuse (NIDA). The primary focus of the grant is to study the company’s lead compound, PPL-138, for the […]

October 6, 2022
BioUtah News
Xenter, the World’s First “TechMed” Company, Unveils the XenFI Wireless Network

Xenter unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem.

October 6, 2022
BioUtah News
Multi-Center Liquid Embolic Study Concludes

Completion of Trial is a Sign of Things to Come for Novel Embolic Agent

September 29, 2022
BioUtah News
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories. […]

September 29, 2022
BioUtah News
BioHive Women in STEM Event recap

BioHive continued its celebration of “STEM September” with the Women in STEM Mingle in downtown Salt Lake City on Tuesday night. Over 65 life science professionals were in attendance to connect with the industry and support the efforts of BioHive.  As a collective, event attendees assembled and packed over 475 Math Learning Kits for Granite […]

September 29, 2022
BioUtah News
2022 Biosphere Magazine Now Available

Each year, BioUtah publishes a special Utah life sciences magazine, Biosphere, released with the September issue of Utah Business Magazine. The 2022 iteration of Biosphere focuses on the incredible innovation taking place within Utah’s life sciences industry.  From Intermountain’s evolution beyond health care delivery to become a life sciences powerhouse within Utah to innovation happening within […]

September 29, 2022
BioUtah News
Excess Equipment Sale for BioUtah Members

Excess Equipment Sale for BioUtah Members